{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:01:06Z","timestamp":1794855666898,"version":"4.9.1"},"reference-count":31,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hereditary hemorrhagic telangiectasia (HHT) is a common bleeding disorder, but little is known regarding prevalence and risk factors for bleeding. Adult discharges with HHT and bleeding were identified by International Classification of Disease, 10th\u00a0edition (ICD-10) codes in the National Inpatient Sample (NIS), 2016-2018. Prevalence estimates were weighted using NIS discharge-level weights to reflect national estimates. Risk factors for bleeding were determined by weighted multivariable logistic regression. Among 18\u2009170\u2009849 discharges, 2528 (0.01%) had HHT, of whom 648 (25.6%) had bleeding. Arteriovenous malformation (AVM) (31.9% vs 1.3%), angiodysplasia (23.5% vs 2.3%), telangiectasia (2.3% vs 0.2%), and epistaxis (17.9% vs 0.6%) were more common in HHT than in non-HHT patients (non-HHT), each\u00a0P &amp;lt; .001. In contrast, menstrual (HMB) and postpartum bleeding (PPH) were less common in reproductive-age HHT than non-HHT, each\u00a0P\u00a0&amp;lt; .001. Anemia associated with iron deficiency (IDA), was equally common in HHT with or without bleeding (15.7% vs 16.0%), but more common than in non-HHT (7.5%),\u00a0P &amp;lt; .001. Comorbidities, including gastroesophageal reflux (25.9% vs 20.0%) and cirrhosis (10.0% vs 3.6%) were greater in HHT than non-HHT, each\u00a0P &amp;lt; .001. In multivariable logistic regression, peptic ulcer disease (OR, 8.86;\u00a0P &amp;lt; .001), portal vein thrombosis (OR, 3.68;\u00a0P = .006), and hepatitis C, (OR, 2.13;\u00a0P = .017) were significantly associated with bleeding in HHT. In conclusion, AVM and angiodysplasia are more common and HMB and PPH less common in patients in those with HHT than non-HHT. IDA deficiency is as common in HHT with and without bleeding, suggesting ongoing blood loss and need for universal iron screening.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023010743","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T22:05:56Z","timestamp":1691791556000},"page":"5843-5850","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":12,"title":["Prevalence and risk factors for bleeding in hereditary hemorrhagic telangiectasia: a National Inpatient Sample study"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8668-6741","authenticated-orcid":false,"given":"Jabra","family":"Zarka","sequence":"first","affiliation":[{"name":"1Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7884-5762","authenticated-orcid":false,"given":"Kwonho","family":"Jeong","sequence":"additional","affiliation":[{"name":"2University of Pittsburgh Center for Research on Health Care Data Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9406-2362","authenticated-orcid":false,"given":"Jonathan G.","family":"Yabes","sequence":"additional","affiliation":[{"name":"2University of Pittsburgh Center for Research on Health Care Data Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7830-5379","authenticated-orcid":false,"given":"Margaret V.","family":"Ragni","sequence":"additional","affiliation":[{"name":"1Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA"},{"name":"3Division of Hematology\/Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA"},{"name":"4Hemophilia Center of Western Pennsylvania, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"issue":"9394","key":"2023101013411179800_bib1","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(03)14696-X","article-title":"Hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease)","volume":"362","author":"Fuchizaki","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"2023101013411179800_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"issue":"13","key":"2023101013411179800_bib3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJM200009283431305","article-title":"Liver disease in patients with hereditary hemorrhagic telangiectasia","volume":"343","author":"Garcia-Tsao","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"2023101013411179800_bib4","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1478-3231.2006.01340.x","article-title":"Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations","volume":"26","author":"Buscarini","year":"2006","journal-title":"Liver Int"},{"issue":"7","key":"2023101013411179800_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/jmg.40.7.494","article-title":"Visceral manifestations in hereditary haemorrhagic telangiectasia type 2","volume":"40","author":"Abdalla","year":"2003","journal-title":"J\u00a0Med Genet"},{"issue":"10","key":"2023101013411179800_bib6","doi-asserted-by":"crossref","first-page":"E591","DOI":"10.1002\/ajh.24832","article-title":"Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia","volume":"92","author":"Kasthuri","year":"2017","journal-title":"Am J Hematol"},{"issue":"9","key":"2023101013411179800_bib7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1288\/00005537-199109000-00008","article-title":"The natural history of epistaxis in hereditary hemorrhagic telangiectasia","volume":"101","author":"AAssar","year":"1991","journal-title":"Laryngoscope"},{"issue":"1","key":"2023101013411179800_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2796.1999.00398.x","article-title":"Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients","volume":"245","author":"Kjeldsen","year":"1999","journal-title":"J\u00a0Intern Med"},{"issue":"2","key":"2023101013411179800_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2009.069013","article-title":"Guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia","volume":"48","author":"Faughnan","year":"2011","journal-title":"J\u00a0Med Genet"},{"issue":"12","key":"2023101013411179800_bib10","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"173","author":"Faughnan","year":"2020","journal-title":"Ann Intern Med"},{"issue":"7","key":"2023101013411179800_bib11","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.2020008739","article-title":"Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care","volume":"137","author":"Al-Samkari","year":"2021","journal-title":"Blood"},{"issue":"8","key":"2023101013411179800_bib12","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3324\/haematol.2020.261859","article-title":"An international, multicenter study of intravenous bevacizumab for bleeding in hereditary telangiectasia: the InHIBIT-Bleed study","volume":"106","author":"Al-Samkari","year":"2021","journal-title":"Haematologica"},{"issue":"9","key":"2023101013411179800_bib13","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/jth.12654","article-title":"Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease","volume":"12","author":"Gaillard","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2023101013411179800_bib14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s42155-021-00270-2","article-title":"Imaging to intervention: a review of what the interventionalist needs to know about hereditary hemorrhagic telangiectasia","volume":"4","author":"Sobrepera","year":"2021","journal-title":"CVIR Endovasc"},{"key":"2023101013411179800_bib15","first-page":"4798425","article-title":"Impact of age on outcomes in hospitalized patients with hereditary hemorrhagic telangiectasia","volume":"2018","author":"Iyer","year":"2018","journal-title":"Adv Hematol"},{"issue":"9","key":"2023101013411179800_bib16","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2018.193003","article-title":"Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist\u2019s perspective","volume":"103","author":"Kritharis","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"2023101013411179800_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1182\/hematology.2021000281","article-title":"Hereditary hemorrhagic telangiectasia (HHT): a practical guide to management","volume":"2021","author":"Hammill","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"2023101013411179800_bib18","doi-asserted-by":"crossref","first-page":"104370","DOI":"10.1016\/j.ejmg.2021.104370","article-title":"The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and specialty care","volume":"65","author":"Shovlin","year":"2022","journal-title":"Eur J Med Genet"},{"issue":"suppl\u00a01","key":"2023101013411179800_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/17474086.2023.2171983","article-title":"Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders","volume":"16","author":"Sidonio","year":"2023","journal-title":"Exp Rev Hematol"},{"key":"2023101013411179800_bib20","unstructured":"HCUP Nationwide Inpatient Sample (NIS)\n          . Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, Rockville, MD. Accessed 15 August 2022. https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp."},{"key":"2023101013411179800_bib21","unstructured":"Classifications of Diseases, Functioning, and Disability, National Center for Health Statistics\n          . International Classification of Diseases, Ninth Revision Clinical Modification (ICD-10-CM). Accessed 15 August 2022. https:\/\/www.icd10data.com."},{"issue":"6","key":"2023101013411179800_bib22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-10-CM 23 administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"1","key":"2023101013411179800_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13023-021-02160-1","article-title":"A\u00a0retrospective cohort study on European Reference Network for Rare Vascular Diseases: 5 outcome measures for hereditary haemorrhagic telangiectasia in Denmark","volume":"17","author":"Hvelplund","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"2023101013411179800_bib24","unstructured":"HHT Foundation International, Inc Monkton MD. Accessed 15 August 2022. https:\/\/curehht.org."},{"issue":"9033","key":"2023101013411179800_bib25","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0140-6736(96)02341-0","article-title":"Randomized study of cognitive effects of iron supplementation in non-anemic iron deficient girls","volume":"348","author":"Bruner","year":"1996","journal-title":"Lancet"},{"issue":"5","key":"2023101013411179800_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2516.1999.00342.x","article-title":"von Willebrand disease and bleeding in women","volume":"5","author":"Ragni","year":"1999","journal-title":"Haemophilia"},{"issue":"6","key":"2023101013411179800_bib27","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1538-7836.2007.02563.x","article-title":"Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease","volume":"5","author":"James","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"2023101013411179800_bib28","first-page":"E123","article-title":"Hereditary hemorrhagic telangiectasia is associated with a higher prevalence of heavy menstrual bleeding [abstract]","volume":"98","author":"Youkhana","year":"2023","journal-title":"Am J Hematol"},{"issue":"1","key":"2023101013411179800_bib29","first-page":"138","article-title":"Systematic review of discharge coding accuracy","volume":"34","author":"Burns","year":"2012","journal-title":"J\u00a0Public Health"},{"issue":"24","key":"2023101013411179800_bib30","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1001\/jama.2012.6626","article-title":"Limitations of administrative databases","volume":"307","author":"Haut","year":"2012","journal-title":"JAMA"},{"issue":"13","key":"2023101013411179800_bib31","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2012.404","article-title":"Finding pure and simple truths with administrative data","volume":"307","author":"Sarrazin","year":"2012","journal-title":"JAMA"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/19\/5843\/2083646\/blooda_adv-2023-010743-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/19\/5843\/2083646\/blooda_adv-2023-010743-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T13:42:31Z","timestamp":1696945351000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/19\/5843\/497419\/Prevalence-and-risk-factors-for-bleeding-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":31,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,10,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010743","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]}}}